 Vancouver, British Columbia and Minneapolis, Minnesota--Newsfile Corp. - April 16, 2021 - Neovasc Inc. NASDAQ: NVCN TSX: NVCN Neovasc or the Company, today announced that the Tiara Transapical system Tiara TA will be unable to receive a European CE mark under the current Medical Device Directive regulations MDD ending on May 26, 2021. The Company is collaborating with its European Notified Body the Notified Body on potential next steps. Neovasc has been working with... 